The Effect of Halotherapy in Chronic Respiratory Disease: An Adjunct to Physiotherapy-A Narrative ReviewApril 2, 2024
Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii InfectionsApril 2, 2024
The Effect of Halotherapy in Chronic Respiratory Disease: An Adjunct to Physiotherapy-A Narrative ReviewApril 2, 2024
Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii InfectionsApril 2, 2024
The Effect of Halotherapy in Chronic Respiratory Disease: An Adjunct to Physiotherapy-A Narrative ReviewApril 2, 2024
Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii InfectionsApril 2, 2024
The Effect of Halotherapy in Chronic Respiratory Disease: An Adjunct to Physiotherapy-A Narrative ReviewApril 2, 2024
Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii InfectionsApril 2, 2024
The Effect of Halotherapy in Chronic Respiratory Disease: An Adjunct to Physiotherapy-A Narrative ReviewApril 2, 2024
Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii InfectionsApril 2, 2024
Vol 1 Issue 2 Mucoadhesion; A Prerequisite or a Constraint in Nasal Drug Delivery?June 28, 2011 International Journal of Pharmaceutical Investigation, 2011, 1, 2, 62-63. DOI: 10.4103/2230-973X.82383 Published: June 2011 Type: Guest Editorial Authors: Kamla Pathak…
Vol 1 Issue 1 Nanoneuropharmacology: A Challenging Concept in Pharmaceutical Investigations for the Next DecadeFebruary 16, 2011 International Journal of Pharmaceutical Investigation, 2011, 1, 1, 2-3. DOI: 10.4103/2230-973X.76720 Published: February 2011 Type: Guest Editorial Authors: Charles Ramassamy…